Researchers sought to determine whether subcutaneous isatuximab would be an effective treatment for patients with RRMM.
Panelists discuss how the subcutaneous nivolumab data demonstrate reassuring safety with minimal grade 3/4 events, how ...
Sometimes, the best way to achieve a big outcome is to start small. That principle is at the center of new work from a ...
Subcutaneous vedolizumab dose intensification restored steroid-free clinical response in approximately one-third of patients with IBD.
New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who ...
The tennis star looked happy and slender in the skimpy baby blue lace-trimmed outfit that made the most of her slender legs.
PORT BYRON, Ill. (KWQC) - Under the Friday night lights, the Riverdale Rams and community, honored the life of one of their own taken too soon. Eric Lange was a Jr. Rams football coach within the ...
Merck (NYSE:MRK) said that the FDA has cleared Keytruda Qlex, a new subcutaneous version of its blockbuster cancer drug, offering a faster alternative to IV infusion, a company spokesperson confirmed ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA QLEX™ (pembrolizumab and ...
PHILADELPHIA -- Saquon Barkley says the Philadelphia Eagles are ready to keep nudging opponents backwards with their controversial play dubbed the "tush push." "They haven't taken it away yet, and ...
For generations, Native Hawaiians have been displaced from ancestral lands, and on the island of Molokai, where one-third of the island is owned by Hong Kong-headquartered billionaire investment firm ...
The institutions published an open letter to defend their missions amid fears the Trump administration could target their tax-exempt status. By Theodore Schleifer Theodore Schleifer covers foundations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results